Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients
M Megna, E Camela, T Battista, L Genco… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction The management of moderate-to-severe forms of psoriasis is becoming a
frequent concern in geriatric age due to the higher risk to develop treatment adverse events …
frequent concern in geriatric age due to the higher risk to develop treatment adverse events …
Treatment approaches to moderate to severe psoriasis
P Gisondi, M Del Giglio, G Girolomoni - International journal of molecular …, 2017 - mdpi.com
Psoriasis is a common disease, which has a considerable impact on patients and the health
care system. Treatment approaches to the disease may be various because some issues …
care system. Treatment approaches to the disease may be various because some issues …
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris–Part 1: treatment and monitoring recommendations
A Nast, C Smith, PI Spuls, G Avila Valle… - Journal of the …, 2020 - Wiley Online Library
This evidence‐and consensus‐based guideline on the treatment of psoriasis vulgaris was
developed following the EuroGuiDerm Guideline and Consensus Statement Development …
developed following the EuroGuiDerm Guideline and Consensus Statement Development …
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris–Part 2: specific clinical and comorbid situations
A Nast, C Smith, PI Spuls, G Avila Valle… - Journal of the …, 2021 - Wiley Online Library
This evidence‐and consensus‐based guideline on the treatment of psoriasis vulgaris was
developed following the EuroGuiDerm Guideline and Consensus Statement Development …
developed following the EuroGuiDerm Guideline and Consensus Statement Development …
Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52‐week results from a phase 3 …
C Bodemer, A Kaszuba, K Kingo… - Journal of the …, 2021 - Wiley Online Library
Background Secukinumab has demonstrated sustained long‐term efficacy with a favourable
safety profile in various psoriatic disease manifestations in adults. Objectives Here, the …
safety profile in various psoriatic disease manifestations in adults. Objectives Here, the …
S3 Guideline for the treatment of psoriasis vulgaris, update–Short version part 1–Systemic treatment
A Nast, L Amelunxen, M Augustin… - JDDG: Journal der …, 2018 - Wiley Online Library
The German guideline for the treatment of psoriasis vulgaris was updated using GRADE
methodology. The guideline is based on a systematic literature review completed on …
methodology. The guideline is based on a systematic literature review completed on …
Treating psoriasis in the elderly: biologics and small molecules
M Megna, L Potestio, G Fabbrocini… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Psoriasis prevalence in the elderly is growing. It is estimated that 15% of elderly
psoriasis patients suffer from moderate-to-severe disease, thus requiring systemic …
psoriasis patients suffer from moderate-to-severe disease, thus requiring systemic …
A deep dive into UV-based phototherapy: Mechanisms of action and emerging molecular targets in inflammation and cancer
PA Vieyra-Garcia, P Wolf - Pharmacology & therapeutics, 2021 - Elsevier
UV-based phototherapy (including psoralen plus UVA (PUVA), UVB and UVA1) has a long,
successful history in the management of numerous cutaneous disorders. Photoresponsive …
successful history in the management of numerous cutaneous disorders. Photoresponsive …
Therapeutic targeting of Th17/Tc17 cells leads to clinical improvement of lichen planus
F Solimani, R Pollmann, T Schmidt, A Schmidt… - Frontiers in …, 2019 - frontiersin.org
Lichen planus (LP) is a common, chronic relapsing inflammatory disorder of the skin and
mucous membranes which often poses a major therapeutic challenge due to its refractory …
mucous membranes which often poses a major therapeutic challenge due to its refractory …
[HTML][HTML] The impact of gender and sex in psoriasis: What to be aware of when treating women with psoriasis
C Guillet, C Seeli, M Nina, LV Maul… - International journal of …, 2022 - journals.lww.com
Background: Psoriasis is a common chronic inflammatory skin disease with an exceptionally
high burden for women. Objective: Sex-dependent differences in disease manifestation …
high burden for women. Objective: Sex-dependent differences in disease manifestation …